1. Medtech Insight
  2. >>Business

Hologic Continues Spending Spree With $230M Tuck-In Acquisition Of Biotheranostics

 
• By Marion Webb

Hologic’s recent buy-outs put it in a strengthened growth and competitive position beyond COVID.

Mergers and acquisition

Hologic, Inc. announced its second acquisition this week and plans to spend $230m for the privately held diagnostics maker BioTheranostics, Inc. to align the company’s broader corporate focus on women’s health. This follows Hologic’s $64m acquisition of SOMATEX Medical Technologies GmbH, which develops minimally invasive devices for tumor diagnostics, biopsy and interventional specialties, announced on 4 January.(Also see "Hologic Acquires Somatex Medical For $64M To Expand Breast Health Care, European Sales Presence" - Medtech Insight, 4 January, 2021.)

“Acquiring Biotheranostics enables us to jump-start our entry into a large, fast-growing oncology adjacency that fits perfectly with our broader...

More from Deals

More from Business

Somnee AI-Powered Sleep Wearable Raises $10M Seed Round

 
• By Natasha Barrow

The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.

Intuitive Surgical Projects $165M Tariff Hit In 2025, Says Wait-And-See On Mitigation

 
• By Shubham Singh

Despite near-term cost pressures, Intuitive Surgical is expanding manufacturing and R&D in North America and Europe to meet demand for Ion, X and Xi systems.

Three Steps To Investor Heaven For Medtech Founders: Articulate, Explain, Clarify

 
• By Ashley Yeo

Capital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.